RaySearch Laboratories AB (publ) (RAY_B) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello and welcome to the presentation of Research Interim Report for the second quarter of 2025. My name is Henrik Prevors, and I will be the moderator today. Joining us in today's call is Johan Lööf, Research Founder and CEO, and Nina Grönberg, our CFO. Johan and Nina will give you a brief summary of the quarter, including the financials, and after that we open up for questions. I also want to remind you that this session is recorded, and you will be able to find our recording on the website on the upcoming days. With that said, I hand over to you, Johan. Please go ahead. Thank you, Henrik. I would also like to welcome all of you to today's webcast. Sales for the second quarter was 305 million Swedish kronor. That is a decrease of 4% compared to the same period in 2024. The weakest sales were partly due to the delay of several orders. Therefore, the order intake in July was unusually high. 56 million Swedish crowns higher than in July last year, and more than 50 million Swedish crowns above the average order intake for the last three years. I'd also like to point out that the revenue for the second quarter of 2024 included a one-time item of 37 million Swedish crowns from a previously prepaid license sale to Medallström, which made the year-on-year comparison more difficult. Operating profit for the quarter came in at 36 million Swedish crowns, translating to an operating margin of 12%. Profit in the second quarter was negatively affected by declining dollar and also some non-recurring costs. If we exclude those effects, the operating profit would have been 51 million Swedish crowns with an operating margin of 17%. Order intake for the second quarter landed at 241 million. As we noted before, order intake can fluctuate significantly between quarters. and that was es...